GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer - Concepedia

Concepedia

Publication | Open Access

GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer

DOI Full Paper Access

34

Citations

26

References

2010

Year

Kristi D. Lynn, D. Gomika Udugamasooriya, Christina L. Roland, Diego H. Castrillón, Thomas Kodadek, Rolf A. Brekken

Abstract

This study demonstrates the VEGFR2 antagonist peptoid, GU81, enhances the anti-tumor activity of doxorubicin in spontaneous murine MMTV-PyMT breast tumors.

References

	Year	Citations

Page 1